학술논문

Peroxisome-derived lipids regulate adipose thermogenesis by mediating cold-induced mitochondrial fission
Document Type
Report
Source
Journal of Clinical Investigation. February, 2019, Vol. 129 Issue 2, p694, 18 p.
Subject
Adipose tissue -- Research
Cardiovascular diseases -- Risk factors
Obesity -- Complications and side effects
Type 2 diabetes -- Risk factors
Enzymes
Oxidases
Oxidation-reduction reactions
Biosynthesis
Fatty acids
Lipids
Dietary supplements
Health care industry
Language
English
ISSN
0021-9738
Abstract
Peroxisomes perform essential functions in lipid metabolism, including fatty acid oxidation and plasmalogen synthesis. Here, we describe a role for peroxisomal lipid metabolism in mitochondrial dynamics in brown and beige adipocytes. Adipose tissue peroxisomal biogenesis was induced in response to cold exposure through activation of the thermogenic coregulator PRDM16. Adipose-specific knockout of the peroxisomal biogenesis factor Pex16 (Pex16-AKO) in mice impaired cold tolerance, decreased energy expenditure, and increased diet-induced obesity. Pex16 deficiency blocked cold-induced mitochondrial fission, decreased mitochondrial copy number, and caused mitochondrial dysfunction. Adipose-specific knockout of the peroxisomal [beta]-oxidation enzyme acyl-CoA oxidase 1 (Acox1-AKO) was not sufficient to affect adiposity, thermogenesis, or mitochondrial copy number, but knockdown of the plasmalogen synthetic enzyme glyceronephosphate O-acyltransferase (GNPAT) recapitulated the effects of Pex16 inactivation on mitochondrial morphology and function. Plasmalogens are present in mitochondria and decreased with Pex16 inactivation. Dietary supplementation with plasmalogens increased mitochondrial copy number, improved mitochondrial function, and rescued thermogenesis in Pex16-AKO mice. These findings support a surprising interaction between peroxisomes and mitochondria regulating mitochondrial dynamics and thermogenesis.
Introduction Obesity remains a serious global health problem that increases the risk for type 2 diabetes and other diseases, including cardiovascular disease and several forms of cancer. Current pharmacological approaches [...]